IU Biostatistics

Indianapolis, Indiana 46202

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Schizophrenia Clinical Trial
The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia
Status: Enrolling, Phase II
Updated: 10/9/2017
IU Biostatistics
mi
from
Indianapolis, IN
Click here to add this to my saved trials